<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: dementia</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Dementia drugs may put some patients at risk, study shows</title>
   	 <description>Side effects associated with several commonly-prescribed dementia drugs may be putting elderly Canadians at risk, says Queen's University Geriatrics professor Sudeep Gill.</description>
     <link>http://www.physorg.com/news162662525.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 27 May 2009 17:02:59 EST</pubDate>
	 <guid isPermaLink="false">news162662525</guid>
</item>
<item>
     <title>Is vitamin D deficiency linked to Alzheimer's disease and vascular dementia?</title>
   	 <description>There are several risk factors for the development of Alzheimer's disease and vascular dementia. Based on an increasing number of studies linking these risk factors with Vitamin D deficiency, an article in the current issue of the Journal of Alzheimer's Disease (May 2009) by William B. Grant, PhD of the Sunlight, Nutrition, and Health Research Center (SUNARC) suggests that further investigation of possible direct or indirect linkages between Vitamin D and these dementias is needed.</description>
     <link>http://www.physorg.com/news162562458.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 26 May 2009 13:14:53 EST</pubDate>
	 <guid isPermaLink="false">news162562458</guid>
</item>
<item>
     <title>AstraZeneca e-mails show debate on Seroquel risks</title>
   	 <description>(AP) --  Marketing executives at British drugmaker AstraZeneca PLC for years blocked efforts by company scientists to raise concerns antipsychotic drug Seroquel caused weight gain and other problems, saying that would harm sales, plaintiff lawyers say.</description>
     <link>http://www.physorg.com/news162041479.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 20 May 2009 12:31:43 EST</pubDate>
	 <guid isPermaLink="false">news162041479</guid>
</item>
<item>
     <title>Early identification of dementia increasingly difficult</title>
   	 <description>If grandma seems to forget things, will she end up demented? These days, memory loss is one of the very few symptoms that may signal which 70-year-olds risk developing dementia. This is shown in a doctoral thesis at the Sahlgrenska Academy at the University of Gothenburg, Sweden.</description>
     <link>http://www.physorg.com/news162040794.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 20 May 2009 12:20:32 EST</pubDate>
	 <guid isPermaLink="false">news162040794</guid>
</item>
<item>
     <title>Weight loss in old age may signal dementia</title>
   	 <description>A new study shows that older people who are thinner or are losing weight quickly  are at a higher risk of developing dementia, especially if they started out overweight or obese. The research is published in the May 19, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.</description>
     <link>http://www.physorg.com/news161883192.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 18 May 2009 16:35:36 EST</pubDate>
	 <guid isPermaLink="false">news161883192</guid>
</item>
<item>
     <title>Postponing retirement may delay dementia</title>
   	 <description>(AP) --  Working a few years beyond retirement could help stave off Alzheimer's disease, according to a new British study published Monday.</description>
     <link>http://www.physorg.com/news161860463.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 18 May 2009 10:14:50 EST</pubDate>
	 <guid isPermaLink="false">news161860463</guid>
</item>
<item>
     <title>New tool can help predict risk of Alzheimer's in elderly</title>
   	 <description>A new tool can help predict whether people age 65 and older have a high risk of developing Alzheimer's disease. Research on the tool is published in the May 13, 2009, online issue of Neurology, the medical journal of the American Academy of Neurology.</description>
     <link>http://www.physorg.com/news161454345.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 13 May 2009 17:26:11 EST</pubDate>
	 <guid isPermaLink="false">news161454345</guid>
</item>
<item>
     <title>Vaccine slows progression of skeletal muscle disorder</title>
   	 <description>A potential vaccine for Alzheimer's disease also has been shown in mice to slow the weakening of muscles associated with inclusion body myositis, a disorder that affects the elderly.</description>
     <link>http://www.physorg.com/news161439371.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 13 May 2009 13:16:42 EST</pubDate>
	 <guid isPermaLink="false">news161439371</guid>
</item>
<item>
     <title>Early Alzheimer's diagnosis offers large social, fiscal benefits</title>
   	 <description>Early diagnosis and treatment of Alzheimer's disease could save millions or even billions of dollars while simultaneously improving care, according to new work by University of Wisconsin-Madison researchers.</description>
     <link>http://www.physorg.com/news161358238.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 12 May 2009 14:44:31 EST</pubDate>
	 <guid isPermaLink="false">news161358238</guid>
</item>
<item>
     <title>A 'light bulb' moment for people with dementia (w/Video)</title>
   	 <description>(PhysOrg.com) -- Change the lighting; improve your health. It's a strategy researchers from Case Western Reserve University's Frances Payne Bolton School of Nursing and the School of Medicine, the Geriatric Research Education and Clinical Center at the Louis Stokes Cleveland Veterans Affairs Medical Center (GRECC), Rensselaer Polytechnic Institute's Lighting Research Center and GE Consumer &amp; Industrial have begun to test in a long-term care facility where daylight, which has proven health benefits, is not readily available.</description>
     <link>http://www.physorg.com/news161350081.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 12 May 2009 12:28:36 EST</pubDate>
	 <guid isPermaLink="false">news161350081</guid>
</item>
<item>
     <title>Compounds in spinal fluid associated with faster decline among individuals with mild dementia</title>
   	 <description>Levels of biomarkers in the cerebrospinal fluid of individuals with very mild dementia may be associated with the rate at which their thinking, learning and memory skills decline, according to a report in the May issue of Archives of Neurology.</description>
     <link>http://www.physorg.com/news161278742.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 11 May 2009 16:39:25 EST</pubDate>
	 <guid isPermaLink="false">news161278742</guid>
</item>
<item>
     <title>Pain relievers seem not to prevent Alzheimer's disease in the very elderly</title>
   	 <description>A new study shows that nonsteroidal anti-inflammatory drugs (NSAIDs), such as the pain relievers ibuprofen and naproxen, do not prevent Alzheimer's disease or other forms of dementia. Instead, the risk of developing dementia in the study's very elderly population (most were over age 83 when they developed dementia) was 66 percent higher among heavy NSAID users than among people who used little or no NSAIDs, according to research published online today in Neurology(R), the medical journal of the American Academy of Neurology.</description>
     <link>http://www.physorg.com/news159640015.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 22 Apr 2009 17:27:27 EST</pubDate>
	 <guid isPermaLink="false">news159640015</guid>
</item>
<item>
     <title>Researchers use eye tracking to detect mild dementia in humans (w/Podcast)</title>
   	 <description>Researchers at the Yerkes National Primate Research Center, Emory University, developed a test in nonhuman primates that is now using infrared eye tracking to detect mild cognitive impairment (MCI) in humans. The researchers hope the advanced technology will be helpful in predicting the onset of Alzheimer's disease. The test, which is featured in the current online issue of The American Journal of Alzheimer's Disease and Other Dementias, is helping researchers further understand the role of the brain structures critical to human memory.</description>
     <link>http://www.physorg.com/news159025771.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 15 Apr 2009 14:51:24 EST</pubDate>
	 <guid isPermaLink="false">news159025771</guid>
</item>
<item>
     <title>Severe hypoglycemia linked with higher risk of dementia for older adults with diabetes</title>
   	 <description>Having hypoglycemic (low blood sugar level) episodes that are severe enough to require hospitalization are associated with a greater risk of dementia for older adults with type 2 diabetes, according to a study in the April 15 issue of JAMA, a theme issue on diabetes. </description>
     <link>http://www.physorg.com/news158926730.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 14 Apr 2009 11:19:50 EST</pubDate>
	 <guid isPermaLink="false">news158926730</guid>
</item>
<item>
     <title>Alzheimer's disease: A new small molecule approach to treatment</title>
   	 <description>New therapeutic approaches in Alzheimer's disease are urgently needed. Work led by Professor Mark Pepys FRS over more than 20 years has identified a protein known as serum amyloid P component (SAP) as a possible therapeutic target in Alzheimer's disease. In collaboration with Roche he developed a new small molecule drug, CPHPC, which specifically targets SAP and removes it from the blood. In the exciting new work reported now in the PNAS, the Pepys team together with Professor Martin Rossor and colleagues from the Dementia Research Centre of UCL's Institute of Neurology, have shown that the drug also removes SAP from the brains of patients with Alzheimer's disease.</description>
     <link>http://www.physorg.com/news158864374.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 13 Apr 2009 18:00:08 EST</pubDate>
	 <guid isPermaLink="false">news158864374</guid>
</item>
<item>
     <title>Researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimer's disease</title>
   	 <description>A recent study by Mount Sinai faculty suggests that a gene associated with onset of type-2 diabetes also decreases in Alzheimer's disease dementia cases. The research, led by Dr. Giulio Maria Pasinetti, MD, Ph.D., The Aidekman Family Professor in Neurology, and Professor of Psychiatry and Geriatrics and Adult Development at Mount Sinai School of Medicine, was published this week in the scientific journal, Archives of Neurology.</description>
     <link>http://www.physorg.com/news158584038.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 10 Apr 2009 12:08:36 EST</pubDate>
	 <guid isPermaLink="false">news158584038</guid>
</item>
<item>
     <title>Alzheimer's disease linked to mitochondrial damage</title>
   	 <description>Investigators at Burnham Institute for Medical Research (Burnham) have demonstrated that attacks on the mitochondrial protein Drp1 by the free radical nitric oxide -which causes a chemical reaction called S-nitrosylation -mediates neurodegeneration associated with Alzheimer's disease. Prior to this study, the mechanism by which beta-amyloid protein caused synaptic damage to neurons in Alzheimer's disease was unknown. These findings suggest that preventing S-nitrosylation of Drp1 may reduce or even prevent neurodegeneration in Alzheimer's patients. The paper was published in the April 3 issue of the journal Science.</description>
     <link>http://www.physorg.com/news157900580.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 02 Apr 2009 14:16:44 EST</pubDate>
	 <guid isPermaLink="false">news157900580</guid>
</item>
<item>
     <title>Effects of disease severity on autobiographical memory in semantic dementia revealed in new study</title>
   	 <description>In a study conducted by the Laboratory of Neuropsychology of the Universit&amp;eacute; de Caen Basse-Normandie and published by Elsevier in the April 2009 issue of Cortex, researchers studied for the first time autobiographical memory in a group of semantic dementia (SD) patients according to disease progression. They highlighted that at early stages of the disease those patients could recall recent memories, but also lasting memories from their youth which tend to disappear as dementia evolves. Mechanisms at the root of this autobiographical memory impairment result from storage deficits combined with faulty retrieval strategies.</description>
     <link>http://www.physorg.com/news157900501.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 02 Apr 2009 14:15:33 EST</pubDate>
	 <guid isPermaLink="false">news157900501</guid>
</item>
<item>
     <title>Nun Study returns to Minnesota, where scientists plan to research Alzheimer's, dementia</title>
   	 <description>Last fall, scientists from the University of Minnesota returned from Kentucky with some 600 preserved brains and 439 boxes filled with memories. That's how the world-famous Nun Study of Alzheimer's disease came home to Minnesota, where it first began.</description>
     <link>http://www.physorg.com/news157228208.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 25 Mar 2009 19:34:08 EST</pubDate>
	 <guid isPermaLink="false">news157228208</guid>
</item>
<item>
     <title>To Fight Drug Addiction, Researchers Target the Brain with Nanoparticles</title>
   	 <description>(PhysOrg.com) -- A precise, new nanotechnology treatment for drug addiction may be on the horizon as the result of research conducted at the University at Buffalo.</description>
     <link>http://www.physorg.com/news157053913.html</link>
	 <category>Nanotechnology</category>
	 <pubDate>Mon, 23 Mar 2009 19:08:59 EST</pubDate>
	 <guid isPermaLink="false">news157053913</guid>
</item>
<item>
     <title>New research highlights dramatically reduced risk of developing dementia</title>
   	 <description>People with memory problems are less at risk of developing dementia than previously thought, a new study led by the University of Leicester and Nottinghamshire Healthcare NHS Trust reveals.</description>
     <link>http://www.physorg.com/news157038529.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 23 Mar 2009 14:49:24 EST</pubDate>
	 <guid isPermaLink="false">news157038529</guid>
</item>
<item>
     <title>Link between epilepsy and Alzheimer`s uncovered</title>
   	 <description>(PhysOrg.com) -- Scientists have discovered what could be causing Alzheimer`s disease sufferers to go on to develop epilepsy.</description>
     <link>http://www.physorg.com/news156698574.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 19 Mar 2009 16:23:38 EST</pubDate>
	 <guid isPermaLink="false">news156698574</guid>
</item>
<item>
     <title>More evidence links diabetes to Alzheimer's risk</title>
   	 <description>(AP) --  You've heard that diabetes hurts your heart, your eyes, your kidneys. New research indicates a more ominous link: That diabetes increases the risk of getting Alzheimer's disease and may speed dementia once it strikes.</description>
     <link>http://www.physorg.com/news156442403.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 16 Mar 2009 17:14:23 EST</pubDate>
	 <guid isPermaLink="false">news156442403</guid>
</item>
<item>
     <title>Shrinking in hippocampus area of brain precedes Alzheimer's disease</title>
   	 <description>People who have lost brain cells in the hippocampus area of the brain are more likely to develop dementia, according to a study published in the March 17, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.</description>
     <link>http://www.physorg.com/news156440974.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 16 Mar 2009 16:51:07 EST</pubDate>
	 <guid isPermaLink="false">news156440974</guid>
</item>
<item>
     <title>Pioneer biomarker test to diagnose or rule out Alzheimer's disease</title>
   	 <description>A test capable of confirming or ruling out Alzheimer's disease has been validated and standardized by researchers at the University of Pennsylvania School of Medicine. By measuring cerebrospinal fluid (CSF) concentrations of two of the disease's biochemical hallmarks - amyloid beta42 peptide and tau protein - the test also predicted whether a person's mild cognitive impairment would convert to Alzheimer's disease over time. Researchers were able to detect this devastating disease at the earliest stages, before dementia symptoms appeared and widespread irreversible damage occurred. The findings hold promise in the search for effective pharmaceutical therapies capable of halting the disease.</description>
     <link>http://www.physorg.com/news156435142.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 16 Mar 2009 15:13:05 EST</pubDate>
	 <guid isPermaLink="false">news156435142</guid>
</item>
<item>
     <title>Variant form of amyloid beta hinders amyloidogenesis, development of Alzheimer's disease</title>
   	 <description>Alzheimer's disease causes misfolding and aggregation of a protein fragment known as amyloid beta and its deposition as plaques in the brain. This process triggers a cascade of event that leads to neurodegeneration. A new study has found that the deadly transformation of amyloid beta into neurotoxic aggregates can be prevented through its interaction with a variant form of the amyloid beta itself. This opens up new prospects for therapies for the disease.</description>
     <link>http://www.physorg.com/news156088909.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 12 Mar 2009 15:02:34 EST</pubDate>
	 <guid isPermaLink="false">news156088909</guid>
</item>
<item>
     <title>Blood test predicts chance of dementia</title>
   	 <description>VIB (the Flanders Institute for Biotechnology, Belgium) researchers connected to the Born-Bunge Institute and the University of Antwerp discovered the amount of growth factor progranulin in blood is a predictor of Frontotemporal Dementia (FTD). Progranulin plays a major role in the survival of brain cells. People producing less progranulin have higher risk of contracting FTD. The researchers developed a test, measuring the amount of progranulin in the blood thus predicting a person's risk. This offers possibilities for early detection.</description>
     <link>http://www.physorg.com/news155558617.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 06 Mar 2009 10:44:08 EST</pubDate>
	 <guid isPermaLink="false">news155558617</guid>
</item>
<item>
     <title>New 'smart' homes for dementia sufferers</title>
   	 <description>Within five years innovative 'smart' sensing systems that will help the UK's 700,000 dementia sufferers live independently at home could be available commercially.</description>
     <link>http://www.physorg.com/news155386837.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 04 Mar 2009 11:01:03 EST</pubDate>
	 <guid isPermaLink="false">news155386837</guid>
</item>
<item>
     <title>Researchers find parental dementia may lead</title>
   	 <description>People who have parents diagnosed with Alzheimer's disease or dementia perform less well on formal memory testing when compared to people of the same age whose parents never developed Alzheimer's disease or other dementia. This is true even in middle-aged persons who do not have a diagnosis of clinical stroke or dementia, according to a Boston University School of Medicine (BUSM) study. This study has been selected to be presented at a Plenary Session at the American Academy of Neurology's 61st Annual Meeting in Seattle, Wash from April 25 - May 2.</description>
     <link>http://www.physorg.com/news154264525.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 19 Feb 2009 11:15:56 EST</pubDate>
	 <guid isPermaLink="false">news154264525</guid>
</item>
<item>
     <title>Having a parent with dementia may affect memory in midlife</title>
   	 <description>People who have parents diagnosed with Alzheimer's disease or dementia may be more likely to have memory loss themselves in middle age, according to a study released today that will be presented at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 to May 2, 2009.</description>
     <link>http://www.physorg.com/news154202503.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 18 Feb 2009 18:02:01 EST</pubDate>
	 <guid isPermaLink="false">news154202503</guid>
</item>


</channel>
</rss>

